Quique Bassat Selected Research

Yaws

1/2018	Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
12/2017	Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study.
1/2016	Mass Treatment with Single-Dose Azithromycin for Yaws.
10/2015	Challenges and key research questions for yaws eradication.
6/2015	Global epidemiology of yaws: a systematic review.
2/2015	Mass treatment with single-dose azithromycin for yaws.
7/2014	Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative study.
4/2014	Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study.
10/2013	Developments in therapy and diagnosis of yaws and future prospects.
1/2012	Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quique Bassat Research Topics

Disease

73	Malaria 01/2022 - 10/2004
33	Infections 12/2021 - 10/2004
19	Falciparum Malaria (Plasmodium falciparum Malaria) 02/2022 - 08/2009
12	Yaws 01/2018 - 03/2011
10	Pneumonia (Pneumonitis) 06/2022 - 12/2009
9	COVID-19 01/2022 - 01/2020
8	Vivax Malaria 12/2021 - 12/2011
8	Hemolysis 01/2021 - 07/2012
6	Diarrhea 12/2021 - 01/2016
5	Bacterial Pneumonia 12/2021 - 10/2010
5	Glucosephosphate Dehydrogenase Deficiency 01/2021 - 07/2012
4	Fever (Fevers) 05/2021 - 02/2008
4	Stillbirth 04/2021 - 10/2019
4	Reinfection 01/2020 - 12/2012
4	Bacteremia 01/2016 - 02/2009
4	Body Weight (Weight, Body) 08/2015 - 09/2011
3	Communicable Diseases (Infectious Diseases) 12/2021 - 03/2016
3	Bacterial Infections (Bacterial Infection) 12/2021 - 02/2016
3	Hemolytic Anemia 04/2019 - 07/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 09/2013
2	Asymptomatic Infections 06/2021 - 01/2017
2	Pneumococcal Infections 12/2020 - 01/2017
2	Cerebral Malaria 10/2020 - 01/2018
2	Anemia 07/2020 - 11/2016
2	Syphilis 07/2014 - 01/2012
2	Filarial Elephantiasis (Lymphatic Filariasis) 05/2013 - 08/2011
1	Virus Diseases (Viral Diseases) 12/2021
1	Coinfection 12/2021
1	Perinatal Death 04/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020
1	Critical Illness (Critically Ill) 01/2020
1	Human Influenza (Influenza) 01/2020

Drug/Important Bio-Agent (IBA)

18	artemisinin (artemisinine)IBA 02/2022 - 02/2008
17	VaccinesIBA 01/2021 - 10/2004
16	Antimalarials (Antimalarial Agents)IBA 02/2022 - 12/2009
13	Pharmaceutical PreparationsIBA 02/2022 - 11/2008
11	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 12/2009
11	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2021 - 11/2008
11	Primaquine FDA Link 01/2021 - 12/2011
10	AntibodiesIBA 01/2022 - 09/2009
9	AntigensIBA 06/2021 - 01/2009
9	ArtesunateIBA 07/2020 - 04/2012
9	Azithromycin (Zithromax)FDA LinkGeneric 01/2020 - 01/2012
9	Immunoglobulin G (IgG)IBA 04/2019 - 09/2009
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
7	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021 - 04/2012
5	insulin receptor-related receptor (IRR)IBA 01/2022 - 03/2014
4	N-methylchlorphentermineIBA 01/2020 - 08/2015
4	Ivermectin (Mectizan)FDA Link 01/2020 - 05/2013
4	InsecticidesIBA 01/2020 - 08/2015
4	TabletsIBA 01/2018 - 11/2008
4	piperaquineIBA 01/2018 - 11/2009
4	ReaginsIBA 12/2017 - 01/2012
4	Malaria VaccinesIBA 01/2012 - 12/2005
3	Biological ProductsIBA 12/2021 - 10/2019
3	Blood Proteins (Serum Proteins)IBA 12/2021 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2016
3	Lysergic Acid Diethylamide (LSD)IBA 01/2021 - 01/2016
3	Amodiaquine (Camoquin)FDA Link 01/2020 - 08/2014
3	artenimol (dihydroartemisinin)IBA 01/2018 - 11/2009
3	Chloroquine (Aralen)FDA LinkGeneric 01/2017 - 12/2011
2	ProcalcitoninIBA 01/2022 - 10/2010
2	C-Reactive ProteinIBA 01/2022 - 10/2010
2	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
2	Conjugate VaccinesIBA 12/2020 - 01/2014
2	Quinine (Quinson)FDA Link 07/2020 - 06/2015
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2020 - 01/2019
2	BCG Vaccine FDA Link 01/2020 - 01/2018
2	Complement System Proteins (Complement)IBA 04/2019 - 02/2008
2	CytokinesIBA 01/2019 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 04/2018 - 01/2017
2	Immunoglobulin M (IgM)IBA 01/2018 - 01/2017
2	EnzymesIBA 01/2017 - 09/2009
2	LigandsIBA 01/2017 - 11/2016
2	Clindamycin (Cleocin)FDA LinkGeneric 10/2016 - 06/2012
2	fosmidomycinIBA 10/2016 - 06/2012
2	Hemoglobins (Hemoglobin)IBA 04/2012 - 01/2011
2	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2012 - 06/2011
1	AS 35IBA 06/2022
1	Valganciclovir FDA Link 06/2022
1	Drug CombinationsIBA 02/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	artesunate drug combination amodiaquineIBA 10/2021
1	arterolaneIBA 10/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2021
1	Immune Sera (Antisera)IBA 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021

Therapy/Procedure

25	Therapeutics 02/2022 - 02/2008
7	Mass Drug Administration 01/2020 - 08/2011
6	Aftercare (After-Treatment) 01/2020 - 03/2011
4	Chemoprevention 01/2020 - 01/2012
2	Personal Protective Equipment 12/2021 - 04/2021
2	Prenatal Care (Care, Prenatal) 05/2021 - 10/2018
1	Treatment Delay 10/2020
1	Blood Transfusion (Blood Transfusions) 07/2020